Tumor-infiltrating lymphocytes (CD8+) and immune checkpoint molecules PD-L1/PD-1 expression were significantly higher in the dMMR group than in the MMR-proficient (pMMR), implying that ICIs could be effective in type I EC with dMMR [38]. Here, CD274 is linked to neoplasm.